Publicaciones en las que colabora con Ana Patiño García (7)

2018

  1. Oral administration of edelfosine encapsulated lipid nanoparticles causes regression of lung metastases in pre-clinical models of osteosarcoma

    Cancer Letters, Vol. 430, pp. 193-200

2017

  1. Doxorubicin and edelfosine lipid nanoparticles are effective acting synergistically against drug-resistant osteosarcoma cancer cells

    Cancer Letters, Vol. 388, pp. 262-268

2015

  1. Antitumoral-Lipid-Based nanoparticles: A platform for future application in osteosarcoma therapy

    Current Pharmaceutical Design, Vol. 21, Núm. 42, pp. 6104-6124

  2. Lipid nanoparticles enhance the efficacy of chemotherapy in primary and metastatic human osteosarcoma cells

    Journal of Drug Delivery Science and Technology, Vol. 30, pp. 435-442

2005

  1. Pediatric meningosarcoma: Clinical evolution and genetic instability

    Pediatric Neurology, Vol. 32, Núm. 5, pp. 352-354

2000

  1. Characteristics and value of chromosome aberrations induced by antitumor treatments in pediatric patients with cancer

    Revista de medicina de la Universidad de Navarra, Vol. 44, Núm. 1, pp. 15-24

  2. Nonclonal chromosomal aberrations induced by anti-tumoral regimens in childhood cancer: Relationship with cancer-related genes and fragile sites

    Cancer Genetics and Cytogenetics, Vol. 121, Núm. 1, pp. 78-85